These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Suppression of antibody synthesis by prostaglandin E as a mechanism for preventing murine immune complex glomerulonephritis. McLeish KR; Gohara AF; Gunning WT Lab Invest; 1982 Aug; 47(2):147-52. PubMed ID: 6213813 [TBL] [Abstract][Full Text] [Related]
24. Experimental membranous glomerulonephritis. The relationship between circulating free antibody and immune complexes to subsequent pathology. Cattran DC; Chodirker WB Nephron; 1982; 31(3):260-5. PubMed ID: 6214723 [No Abstract] [Full Text] [Related]
25. [New facts and trends on research on the pathogenesis of immune glomerulonephritis]. Belobezhdov N Vutr Boles; 1982; 21(3):1-8. PubMed ID: 6214082 [No Abstract] [Full Text] [Related]
26. Circulating immune complexes in patients with glomerulonephritis and in renal transplant patients. Sølling J Scand J Urol Nephrol Suppl; 1985; 97():1-46. PubMed ID: 3915401 [No Abstract] [Full Text] [Related]
27. [The skin in chronic immune complex mesangioproliferative glomerulonephritis]. Ludwig H; Schernthaner G; Pinggera W Verh Dtsch Ges Inn Med; 1978; (84):1253-6. PubMed ID: 741940 [No Abstract] [Full Text] [Related]
28. [Experimental immune complex glomerulonephritis with 2 types of immune complexes]. Kubes L Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1980; 23(4):385-414. PubMed ID: 6971478 [No Abstract] [Full Text] [Related]
29. Removal of glomerular immune complex deposits by excess antigen in chronic mouse model of immune complex disease. Haakenstad AO; Striker GE; Mannik M Lab Invest; 1983 Mar; 48(3):323-31. PubMed ID: 6219249 [No Abstract] [Full Text] [Related]
30. [Diagnostic and prognostic value of the immunofluorescence technic in renal pathology]. Senchik RV; Pigareva NV; Klemina IK; Shishkin VI Ter Arkh; 1981; 53(1):98-101. PubMed ID: 6452713 [No Abstract] [Full Text] [Related]
33. Nephritogenic immune reactions involving immune complex formation in the circulation and in situ within the kidney. Wilson CB; Neale TJ; Holdsworth SR Aust N Z J Med; 1981; 11(Suppl 1):88-93. PubMed ID: 6455118 [TBL] [Abstract][Full Text] [Related]
34. Immune complex disease. V. The nature of the circulating complexes associated with glomerular alterations in the chronic BSA-rabbit system. Germuth FG; Senterfit LB; Dreesman GR Johns Hopkins Med J; 1972 Jun; 130(6):344-57. PubMed ID: 5031005 [No Abstract] [Full Text] [Related]
35. Immunologically mediated glomerulitis of horses. I. Pathogenesis in persistent infection by equine infectious anemia virus. Banks KL; Henson JB; McGuire TC Lab Invest; 1972 Jun; 26(6):701-7. PubMed ID: 4337973 [No Abstract] [Full Text] [Related]
36. [Immune complexes: studies on animal models]. Albini B; Penner E; Knoflach P Wien Klin Wochenschr; 1985 Apr; 97(8):363-9. PubMed ID: 3158121 [TBL] [Abstract][Full Text] [Related]
37. [Value of serological studies of the complement system in glomerulonephritis]. Szewczyk Z; Klinger M; Strychowski J Pol Tyg Lek; 1982 Aug; 37(29-30):869-73. PubMed ID: 6218487 [No Abstract] [Full Text] [Related]
38. The formation and fate of glomerular immune complex deposits. Furness PN J Pathol; 1991 Jul; 164(3):195-202. PubMed ID: 1890546 [No Abstract] [Full Text] [Related]
39. The immunopathogenesis of glomerulonephritis: muddied waters. Neale TJ N Z Med J; 1983 Aug; 96(737):622-5. PubMed ID: 6223242 [No Abstract] [Full Text] [Related]